General information

• Cerasus Journal of Medicine (Cerasus J Med) is an international, double-blind, peer-reviewed scientific journal that publishes manuscripts describing clinical research in medicine.
• The articles are written in English.

• Cerasus Journal of Medicine is a journal published three times a year in January, May, and September.

• The overall similarity ratio should not exceed 20% (excluding the reference list). Furthermore, no single source should have a similarity ratio exceeding 3%.
• Manuscripts that comply with the Cerasus Journal of Medicine submission guidelines and are deemed appropriate for the scope of the journal are sent to at least two referees who are experts in their fields.
• Manuscripts must describe original data that have not been published previously nor submitted for publication elsewhere.
• The members of the Editorial Board who discuss the suitability then consider the reviewers’ comments on each submission.
• The final decision for all submitted manuscripts rests with the Editor-in-Chief.
• Manuscripts to be published must be sent via the “Submit Article” page.

Institutional review board/ethics committee approval (IRB)

If a study involves either human subjects, human-derived materials, and/or medical records, authors must include in the Methods section either a statement that an Institutional Review Board (IRB)/Ethics Committee approval has been obtained or a statement that the IRB/Ethics Committee has ruled that approval was not required for the study. When reporting experiments conducted with humans, it is indicated that the procedures were in accordance with ethical standards set forth by the committee that oversees human experimentation. Approval of research protocols by the relevant ethics committee, in accordance with international agreements (World Medical Association Declaration of Helsinki, latest version, available at https://www.wma.net/policies-post/wma-declaration-of-helsinki/, “Guide for the Care and Use of Laboratory Animals” www.nap.edu/catalog/5140.html/), is required for all experimental, clinical, and drug studies. Patient names, initials, and hospital identification numbers should not be used. Manuscripts reporting the results of experimental investigations conducted with humans must state that the study protocol received institutional review board approval and that the participants provided informed consent.

Permissions

Authors who wish to include figures, tables, or text fragments that have been previously published elsewhere should definitely cite the relevant place in the article. If not cited, they must obtain permission from the copyright holder(s) for the relevant portion and include proof of such permission when submitting their manuscript. Without such proof, any material cited will be assumed to belong to the authors. No material, such as clinical images or charts, photos, and graphs, as well as images of devices that may have been obtained from their producers, can be published without such permission.

Article Submission Phase

Required files to be uploaded when submitting an article:
1- A Word File of the article prepared in accordance with the editorial guidelines (No information about the authors should be included. This file will be sent to the reviewers in accordance with the double-blind review policy.)
2- The "Title Page" must be completely filled out and uploaded to the system.
3- Copyright Agreement and Author Acknowledgement Form
4- A similarity report must be uploaded to the system.
5- The approved version of the Ethics Committee Permit must be uploaded to the system. If the study does not require ethics committee approval, upload a file indicating this. In addition, this approval (name, date, and number of the committee) must be stated in the "Article Information Form" at the end of the study

Article Types

All studies published in the Cerasus Journal of Medicine are peer-reviewed according to a double-blind peer-review policy.

Original Article: An article is a full-length report on original primary research that will interest the journal's readers. They must describe significant and original observations.

Review Article: The review article is a comprehensive analysis of specific topics and recent developments in a particular area. A review should focus on recent research and issues. It should also include the authors' opinions on how to approach the topic/situation under discussion and what is needed to advance the field in the future. Authors who are experts on the subject may be invited by the editors to write review articles.

Case Report: Case reports and case studies should present significant new insights or cases with an unusual and noteworthy course of events. It is recommended that case reports include an up-to-date review of all previous cases in the field. The novelty of the case(s) may lie in the phenotype, the presentation, the investigation, and/or the management. Case reports may be from the year the article was submitted or the previous year. Case reports from earlier years will not be considered for review. 

Letter to the Editor: Formal commentary on published articles may take the form of critiques, requests for clarification or, on occasion, replication efforts. Following peer review, these contributions are posted online as 'Letters to the Editor', usually alongside a response from the original authors. Letters to the Editor and replies are linked to the original published paper. The journal will not consider letters about work published elsewhere. Submissions that do not meet our guidelines will not be considered for publication. They must be written in a neutral register, and all points raised must pertain directly to the original article. They should not present preliminary observations that require validation in a subsequent paper. All such submissions are peer reviewed.

Pictorial Essay: This is a continuing medical education exercise that conveys the teaching message through the figures and their accompanying legends. Text should include a brief abstract. No new information is included. The value of the paper turns on the quality of the illustrations. Authors can submit dynamic images (e.g. video files) or include supplemental image files for online presentation that further illustrate the educational purpose of the essay. 

Editorial: Special articles are written by the editor or editorial board members. An abstract is not usually included in editorials.

Manuscript preparation

• Articles should be written in a single spaced using Microsoft Word, leaving 2.5 cm margins on all sides.
• Paragraphs should not be indented.
• For equations, use either the equation editor or MathType.
• For tables, use the table function, not spreadsheets.
• Once accepted, Cerasus Journal of Medicine will convert the manuscript to a double-column format.

Download the WORD file for the sample file.

Table-1.  Limitations for each manuscript type

* For "Word Limit", abstracts and references are excluded.

Title: A title that accurately describes the article and is concise is preferred. Only the first letter of each word in the title should be capitalized.

Authors: Author names must be clearly written. Abbreviations must not be used. Each author's ORCID ID number must be written. Each author's institution must be listed in the order Department, Faculty, University, City, and Country. If available, the institution’s ROR ID must be written after the address.

Abstract: The word limit in the abstracts should be written according to the numbers in the table above, and it should include the following subheadings: Objective, Methods, Results, Conclusion.

Keywords: Keywords are required for indexing and abstracting services. The keywords that will best express the work should be determined.

Main text: The main text of an original article should be divided into INTRODUCTION, METHODS, RESULTS, DISCUSSION, and CONCLUSION sections. The case report should include an abstract, introduction, case report, discussion, and references. Abbreviations must be defined following their first use in the Abstract as well as in the main text and in the figures and tables. Only commonly accepted abbreviations should be used. Drug and chemical names should be stated using generic or standard chemical nomenclature. Units of measurement should conform to the International System (SI); however, clinical data may be presented in conventional units where deemed more appropriate.

Headings and subheadings:

• Main headings (e.g. INTRODUCTION, METHODS, RESULTS, DISCUSSION) and the word REFERENCES should be written in capital letters.
• In subheadings, only the first letter of each word should be capitalised.

Footnotes:

• Footnotes may be used to provide supplementary information, but they should not contain reference citations, which are included in the reference list at the end of the manuscript. They must also not contain figures or tables. 
• Footnotes should be numbered consecutively for the title page, main text, and each table. 
• Footnotes should be indicated by lowercase superscript letters or numbers, or asterisks for significance values and other statistical data. 
• Footnotes should be positioned at the bottom of the page or table in which they appear.

Tables

• Tables capture and display information concisely and efficiently, and they can provide information at any desired level of detail and precision. Including data in tables rather than in the text can often reduce the text's length.
• Tables must be numbered consecutively in the order in which they appear in the text (e.g. Table 1, Table 2, etc.). Place table titles above the table in 10-point Times New Roman font. The table content should also be written in 10-point Times New Roman font. If a table does not fit within a page, the font size can be reduced accordingly. Statistically significant values should be presented in bold. If the table has a source, this should be indicated below the table in 9–10 pt Times New Roman font. Only the first letter of the first word in the table title should be capitalised. All other words should be lowercase (except for proper nouns).
• Authors should include any necessary additional information in notes below the table, rather than in the title.
• Ensure that each table is cited in the text. If you use data from another published or unpublished source, obtain permission and fully acknowledge that source.
• Additional tables containing backup data that is too extensive to publish in print may be suitable for publication in the electronic version of the journal, for deposit with an archival service, or for direct availability to readers from the authors. An appropriate statement should be added to the text. Such tables should be submitted with the paper for consideration so that they will be available to the peer reviewers.

Figures

• Figures should be numbered consecutively according to their order of citation in the text.
• Figure titles should be placed below the figure in Times New Roman at a font size of 10 points. If the figure does not fit within the page, reduce the font size accordingly. If the figure has a source, this must be indicated below the title in 10-point Times New Roman font. Arabic numerals corresponding to the images should be used for image captions.
• Only the first letter of the first word in the figure title should be capitalised. All other words should be lowercase, except for proper nouns.
• Titles and detailed explanations belong in the legends, not on the illustrations themselves.
• Photographs of potentially identifiable individuals must be accompanied by written consent for their use.
• The internal scale should be explained, and the staining method in the photomicrographs should be identified. Only the first letter of the first word in the figure title should be capitalised. All other words should be lowercase (except for proper nouns).
• If a figure has been published previously, the original source must be acknowledged, and written permission from the copyright holder must be obtained to reproduce the figure. Permission is required irrespective of authorship or publisher, except for documents in the public domain. 
• Figures should be professionally drawn or photographed, or submitted as digital prints of photographic quality. In addition to providing a version of the figures suitable for printing, authors should also supply electronic files of the figures in a format (such as JPEG or GIF) that will produce high-quality images for the online version of the journal. Authors should review the images of these files on a computer screen before submitting them to ensure they meet their own quality standards.
• For X-ray films, scans and other diagnostic images, as well as pictures of pathology specimens or photomicrographs, sharp, glossy black-and-white or colour photographic prints should be sent, typically measuring 127 x 173 mm. The letters, numbers, and symbols on the figures must be clear and consistent throughout and large enough to remain legible when the figure is reduced for publication.
• Figures should be as self-explanatory as possible since many will be used directly in slide presentations.
• Photomicrographs should have internal scale markers. Any symbols, arrows, or letters used in photomicrographs must contrast with the background.
   

Article Information Form

The article information form should be written after the text, before the references. Explain the following headings in detail.
Acknowledgments: 
Financial Disclosure: 
Conflicts of interest:
Ethical Declaration: 
Artificial Intelligence Statement:
Author Contributions: (The statement "Authors' contribution to the article is equal" is not accepted.) To be considered as an author of an article, a writer must have contributed to at least 3 of the following. If any of the following headings are not relevant to your work, please mark them as "None".
Conceptualization: F.A., S.A.;
Methodology: F.A., S.A.;
Software: T.A.;
Validation: F.A., T.A.;
Formal analysis: S.A.;
Investigation: F.A.;
Resources: T.A.;
Data curation: F.A.;
Writing – original draft: S.A.;
Writing – review & editing: F.A.;
Visualization: S.A.;
Supervision: None;
Project administration: F.A., S.A.;
Funding acquisition: None.;

Reference Style and Format

• References in the article should be written in Vancouver style.
• Citing a "personal communication" should be avoided unless it provides essential information not available from a public source, in which case the name of the person and date of communication should be cited in parentheses in the text. For scientific articles, written permission and confirmation of accuracy from the source of a personal communication must be obtained.
• Authors are encouraged to cite primary literature rather than review articles in order to give credit to those who have performed the original work. When citing publications, preference should be given to the most recent and up-to-date ones.
• The titles of journals should be abbreviated according to the style used in the list of Journals in Index Medicus. Additionally, the list should be obtained from the web address http://www.nlm.nih.gov. If a journal is not indexed in Index Medicus, it should not be abbreviated.
• References must be numbered in square brackets within the article and listed in order of their first appearance in the text.
• If there are more than 6 authors, write the first 6 authors according to the rule and use et al. for the subsequent authors.
• If the article has a DOI number, it must be included in the references.
• All references should be cited in text.
• Accuracy of citation is the author's responsibility.

The reference styles for different types of publications are presented in the following examples:

For journals

Articles in journals

For the published article from the journal, which is placed and abbreviated in Medline:

• Polyakova M, Stuke K, Schuemberg K, Mueller K, Schoenknecht P, Schroeter ML. BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis. J Affect Disord. 2015;174:432-40. doi:10.1016/j.jad.2014.11.044.
• Ganguly S, McRae J, He J, Divine C, Abhyankar S, Aljitawi O, et al. Routine radiographic screening after completion of initial chemotherapy and relapse-free survival after transplant in patients with relapsed lymphoma. Leuk Lymphoma. 2015;56(2):518-9. Epub 2014 Jul 15. doi:10.3109/10428194.2014.921916.

• Morehouse R, Macqueen G, Kennedy SH. Barriers to achieving treatment goals: a focus on sleep disturbance and sexual dysfunction. J Affect Disord. 2011;132(Suppl 1):S14-20. doi:10.1016/j.jad.2011.03.047.

For the published article from the journal that is not placed and is not abbreviated in Medline:

• Gokdemir O, Karaman Ulutan A. Dietary supplements and side effects: persistent atrial fibrillation. DAHUDER Medical Journal. 2022;2(4):120-3. doi:10.56016/dahudermj.1184388.

Articles in press

• Wan Y, Fan K, Ye X. Efficacy and safety of neuromodulation techniques in depression treatment: a systematic review and meta-analysis. Psychiatry Clin Psychopharmacol. 2025. In press. doi:10.5152/pcp.2025.241065.
• Goodwin GM, Nowakowska A, Atli M, Dunlop BW, Feifel D, Hellerstein DJ, et al. Results from a long-term observational follow-up study of a single dose of psilocybin for a treatment-resistant episode of major depressive disorder. J Clin Psychiatry. 2025. In press.

Article with published erratum

• Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, et al. Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2017;102(11):3869–903. Erratum in: J Clin Endocrinol Metab. 2018;103(2):699. Erratum in: J Clin Endocrinol Metab. 2018;103(7):2758–9.
• Foreman M, Hare L, York K, Balakrishnan K, Sánchez FJ, Harte F, et al. Genetic link between gender dysphoria and sex hormone signaling. J Clin Endocrinol Metab. 2019;104(2):390–6. doi: 10.1210/jc.2018-01105. Erratum in: J Clin Endocrinol Metab. 2020;105(1):dgz156. doi:10.1210/clinem/dgz156.

Volume with supplement

• Miller S, Dell’Osso B, Ketter TA. The prevalence and burden of bipolar depression. J Affect Disord. 2014;169(Suppl 1):S3–11.

Issue with supplement

• Hagell P, Knutsson I. Single-item assessment of perceived health in neurological disorders: verbal response categories vs visual analog scale. Qual Life Res. 2013;22(1 Suppl):116–117.

Volume with part

• Kitazawa T, Eto M, Woodsome TP, Khalequzzaman M. Phosphorylation of the myosin phosphatase targeting subunit and CPI-17 during Ca2+ sensitization in rabbit smooth muscle. J Physiol. 2003;546(Pt 3):879–89.

Issue with part

• Porrello ER, Olson EN. A neonatal blueprint for cardiac regeneration. Stem Cell Res. 2014;13(3 Pt B):556–70. 

Issue with no volume

• Baumeister AA. Origins and control of stereotyped movements. Monogr Am Assoc Ment Defic. 1978;(3):353–84.

No volume or issue

• Zhang Y, Patel R. Telehealth counseling for adolescent weight management: feasibility findings. Digital Health Brief. 2022 Sep:22–9.

Journal article on the Internet

• Schure MB, Lindow JC, Greist JH, Nakonezny PA, Bailey SJ, Bryan WL, et al. Use of a fully automated internet-based cognitive behavior therapy intervention in a community population of adults with depression symptoms: randomized controlled trial. J Med Internet Res [Internet]. 2019 Nov 18 [cited 2025 Sep 27];21(11):e14754. Available from: https://doi.org/10.2196/14754

For books and other monographs

Personal author(s)

• Fletcher RH, Fletcher SW. Clinical epidemiology: the essentials. 4th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2005.
• Celentano DD, Szklo M. Gordis epidemiology. 6th ed. Philadelphia (PA): Elsevier; 2019.

Author(s) and editor(s)

• Smith A. An inquiry into the nature and causes of the wealth of nations. Cannan E, editor. London: Methuen; 1904.
• Kant I. Critique of pure reason. Guyer P, Wood AW, editors. New York (NY): Cambridge University Press; 1998.

Organization(s) as author

• World Health Organization. World health statistics 2023: monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization; 2023. 130 p.
• Organisation for Economic Co-operation and Development (OECD). Health at a Glance 2023: OECD indicators. Paris: OECD Publishing; 2023. 234 p.

Editor(s), compiler(s) as author

• Cherry JD, Demmler-Harrison GJ, Kaplan SL, Steinbach WJ, Hotez PJ, editors. Feigin and Cherry’s textbook of pediatric infectious diseases. 8th ed. Philadelphia (PA): Elsevier; 2019.
• Libby P, Bonow RO, Mann DL, Tomaselli GF, Bhatt DL, Solomon SD, et al., editors. Braunwald’s heart disease: a textbook of cardiovascular medicine. 12th ed. Philadelphia (PA): Elsevier; 2022.

Translated book

• Kant I. Critique of pure reason. Guyer P, Wood AW, translators. Cambridge (UK): Cambridge University Press; 1998.
• Husserl E. The crisis of European sciences and transcendental phenomenology. Carr D, translator. Evanston (IL): Northwestern University Press; 1970.

Chapter in a book

• Avila-Tang E, Matsui E, Wiesch DG, Samet JM. Epidemiology of asthma and allergic diseases. In: Adkinson NF Jr, Bochner BS, Busse WW, Holgate ST, Lemanske RF Jr, Simons FER, editors. Middleton’s allergy: principles and practice. Vol. 2. 7th ed. Philadelphia (PA): Mosby Elsevier; 2008. p. 715–767.
   
• Guilbert TW, Moss MH, Lemanske RF Jr. Approach to infants and children with asthma. In: Adkinson NF Jr, Holgate ST, Bochner BS, Busse WW, Lemanske RF Jr, Simons FER, editors. Middleton’s allergy: principles and practice. 7th ed. Philadelphia (PA): Mosby Elsevier; 2009. p. 1319–1343.

Conference proceedings

• Halliday RB, Walter DE, Proctor HC, Norton RA, Colloff MJ, editors. Acarology: Proceedings of the 10th International Congress; 1998 Jul 5–10; Canberra, Australia. Melbourne: CSIRO Publishing; 2001. 
• Gagos T, Hyatt A, editors. Proceedings of the 25th International Congress of Papyrology; 2007 Jul 29–Aug 4; Ann Arbor (MI), USA. Ann Arbor (MI): Scholarly Publishing Office, University of Michigan Library; 2010.

Dissertation (Thesis)

• Lim DHK. The clinical and molecular genetic investigation of genetic conditions predisposing to kidney cancers [dissertation]. Birmingham (UK): University of Birmingham; 2018.
• Bansal Y. Building the theoretical foundations of deep learning: an empirical approach [dissertation]. Cambridge (MA): Harvard University Graduate School of Arts and Sciences; 2022.
   
• Sürer S. From space to safety: flood mapping with Sentinel-1 SAR data for enhancing flood risk management in Ljungby Municipality [master’s thesis]. Lund (SE): Lund University; 2024 [Internet]. [cited 2025 Nov 22]. Available from: https://lup.lub.lu.se/student-papers/record/9158441

Poster(s)

• Frances C, Duñabeitia JA. Ew! Disgust perception in native and foreign languages [poster]. Presented at: 20th Conference of the European Society for Cognitive Psychology (ESCoP); 2017 Sep 3–6; Potsdam, Germany.
   
• Penafiel D, Termote C, Espinel R, Van Damme P. Traditional food consumption by indigenous women in Guasaganda, Central Ecuador [poster]. Presented at: European OneHealth/EcoHealth Workshop; 2016 Oct 6–7; Brussels, Belgium.

Patent

• Pagedas AC, inventor; Ancel Surgical R&D Inc., assignee. Flexible endoscopic grasping and cutting device and positioning tool assembly. United States patent US 20020103498. 2002 Aug 1.

Homepage/Website

• World Health Organization (WHO) [Internet]. Geneva (CH): World Health Organization; c1948– [cited 2025 Sep 27]. Available from: https://www.who.int/

Proofreading

After the Cerasus Journal of Medicine has prepared the layout of the article, it is sent to all authors for proofreading. All authors must view the pre-publication version of the article and approve its publication.

Multicenter clinical trials

The Cerasus Journal of Medicine welcomes submissions of manuscripts reporting the results of multicentre clinical trials. These manuscripts may be submitted with authorship in one of the following styles:
    • The name of a study group only (collective authorship).
    • The names of no more than five individuals, along with the name of a study group.
In each case, one individual must serve as the corresponding author. The names of all individuals involved in preparing the manuscript should be listed under the 'Writing Committee' heading, after the 'Acknowledgements' section. This should be followed by a list of investigators from each institution under the heading 'Study Group Investigators'. All authors and Writing Committee members must sign the Copyright Agreement and Author Acknowledgement Form.

Responsibility for content

• The authors are solely responsible for the content and scientific accuracy of all manuscripts, as well as any electronic supplementary material. 
   
• The Cerasus Journal of Medicine will not accept any responsibility for any legal claims arising from injury and/or damage to persons or property, whether relating to product liability, negligence, or other circumstances, nor for any use or operation of the methods, products, instructions, or ideas contained in the published material.
   
• Readers should not conduct any test or procedure unless they are certain it is safe.
   
• Independent verification of all diagnoses and drug dosages is required. 
   
• Any discussions, views, or recommendations regarding medical procedures, drug choices, or dosages are the sole responsibility of the authors.

Disclaimer
Cerasus Journal of Medicine does not accept or publish advertisements. Any mention of commercial products, if it occurs within scholarly content, does not imply endorsement by the journal.

Cerasus Journal of Medicine (CJM) is an international, peer-reviewed medical journal that operates on a double-blind evaluation system and publishes high-quality research across all fields of medicine. The journal adheres to the highest ethical and scientific standards, following the guidelines of COPE, ICMJE, Declaration of Helsinki, and WAME to ensure integrity, transparency, and accountability in scholarly publishing.

Author Responsibilities

Authors must:

Submit only original, unpublished manuscripts that are not simultaneously under consideration elsewhere.

Provide documented ethical approval and informed consent for studies involving human participants, animals, biological materials, or sensitive data.

Avoid all forms of research and publication misconduct, including plagiarism, duplication, data fabrication, falsification, and redundant publication.

Meet the ICMJE authorship criteria; honorary, guest, or ghost authorship is strictly prohibited.

Provide valid ORCID iDs for all authors.

Disclose all actual or potential conflicts of interest transparently.

Acknowledge all funding sources, institutional contributions, and relevant support.

Ensure the accuracy, reliability, and reproducibility of the research data.

Revise manuscripts promptly and thoroughly in accordance with editorial and reviewer comments.

Editor Responsibilities

Editors are responsible for:

Ensuring an impartial, unbiased, and scientifically robust evaluation of all submitted manuscripts.

Declining to handle any manuscript for which they have actual or potential conflicts of interest.

Maintaining strict confidentiality regarding all submitted materials, including manuscript content, author identities, and reviewer reports.

Selecting highly qualified reviewers and ensuring the integrity and transparency of the double-blind peer-review process.

Providing clear, consistent, and well-substantiated justifications for all editorial decisions.

Addressing ethical concerns or allegations of misconduct through fair, transparent, and systematic procedures aligned with international best editorial practices.

Reviewer Responsibilities

Reviewers must:

Conduct objective, constructive, and timely evaluations based solely on scientific merit.

Maintain complete confidentiality and refrain from sharing or using manuscript content for personal or professional gain.

Decline review invitations when conflicts of interest exist or when they lack the necessary expertise to provide a qualified assessment.

Provide evidence-based, respectful, and improvement-oriented feedback to support the advancement of scientific quality.

Report any suspected ethical violations—such as plagiarism, data manipulation, or duplicate publication—directly and promptly.

Peer-Review Process

Cerasus Journal of Medicine (CJM) employs a rigorous double-blind peer-review system, ensuring anonymity for both authors and reviewers throughout the evaluation process.

Manuscripts that successfully pass the preliminary editorial screening are assigned to at least two independent experts with relevant academic competence.

Editorial decisions—accept, revise, or reject—are based on reviewer reports, scientific merit, methodological soundness, and overall contribution to the field.

The average peer-review duration is 40-60 days, although this may vary depending on the reviewer's availability and the revision requirements.

Plagiarism and Similarity Check Policy

All manuscripts submitted to CJM are screened for originality as part of the editorial evaluation process. The journal follows strict guidelines to prevent plagiarism and unethical text reuse. Detailed procedures, similarity thresholds, and author responsibilities are outlined in the CJM Plagiarism Policy. Authors are required to review and comply with the full policy, available on the journal’s dedicated plagiarism policy page.

Research Ethics

Human and Animal Research

Studies involving humans must have ethics committee approval, comply with the Declaration of Helsinki, and include informed consent procedures.

Clinical trials must provide registry details.

Animal studies must adhere to recognized international standards of animal welfare.

Data Transparency

Authors must be prepared to provide raw data to the editors upon request for verification.

Any form of data manipulation—such as fabrication, falsification, or selective reporting—is considered serious scientific misconduct.

Conflict of Interest Policy

All authors, reviewers, and editors are required to disclose any financial, personal, institutional, or professional conflicts of interest that may influence the research or evaluation process.

Individuals with declared conflicts must be recused from the editorial decision-making or review process to ensure impartiality and integrity.

Artificial Intelligence (AI) Use Policy

CJM acknowledges the increasing importance of AI tools in academic workflows. To protect research integrity and ensure transparency, the following rules apply:

Acceptable AI Use

AI tools may be used for:

Language editing and grammar improvement.

Statistical assistance or computational support.

Non-manipulative image processing.

Coding, data visualization, or technical formatting.

Prohibited AI Use

AI tools must not be used to:

Generate scientific content, results, hypotheses, or interpretations.

Fabricate, falsify, or manipulate data, images, or references.

Write substantial portions of the manuscript.

Perform any action that compromises the integrity or originality of the work.

Mandatory AI Disclosure

Authors must explicitly disclose all AI tool usage in the Methods or Acknowledgments section, specifying the tool and purpose.

Failure to disclose constitutes academic misconduct.

Example disclosure:

“ChatGPT (OpenAI) was used for language editing only; no AI tool was used to generate scientific content or interpret findings.”

AI cannot be an Author.

AI tools cannot meet authorship criteria and, therefore, may not be listed as authors.

Authors bear full responsibility for the accuracy, originality, and integrity of all submitted content.

Retraction, Withdrawal, and Correction Policy

Retraction

Retraction may occur when:

Plagiarism, fabrication, or falsification is confirmed.

Duplicate publication is detected.

Major errors fundamentally affect the study’s conclusions.

Ethical violations compromise scientific reliability.

Retracted articles remain publicly accessible with a “RETRACTED” watermark and an explanatory retraction notice.

Withdrawal

Withdrawal requests must include a formal written justification.

Unjustified withdrawal requests submitted after peer review has begun may be classified as unethical publishing behavior.

Corrections

Corrections (corrigenda, errata, or addenda) are issued when minor errors do not invalidate the overall findings but require clarification.

Misconduct Handling and Editorial Communication

Misconduct Handling

CJM investigates all allegations of ethical misconduct through a structured process involving:

Initial editorial review of the concern

Request for author clarification or supporting documentation

Consultation with reviewers or external experts, if needed

Implementation of appropriate actions, including revision requests, rejection, correction, retraction, or institutional notification

Official Editorial Communication Address

All manuscript submissions, editorial evaluations, revision requests, reviewer reports, editorial decisions, and post-acceptance processes are conducted through the DergiPark online submission system.

The official editorial communication addresses of Cerasus Journal of Medicine are kubila.yssever@gmail.com and kubilay.issever@giresun.edu.tr. These addresses are used only for matters that cannot be handled through the DergiPark system, including ethical inquiries, complaints, appeals, authorship clarification, suspected misconduct, technical problems, and other formal administrative correspondence.

Authors are responsible for regularly checking both the DergiPark system and their registered e-mail addresses for updates regarding their submissions. Failure to respond to editorial requests within the specified time may delay the review or publication process and may result in administrative action, including withdrawal of the manuscript from the editorial process.

Submissions sent directly by e-mail are not considered for evaluation. All manuscripts must be submitted through the DergiPark online submission system.